ECSP099192A - SPECIFIC HUMAN MONOCLONAL ANTIBODIES FOR HUMAN LIGHT ANTAGONISTS - Google Patents
SPECIFIC HUMAN MONOCLONAL ANTIBODIES FOR HUMAN LIGHT ANTAGONISTSInfo
- Publication number
- ECSP099192A ECSP099192A ECSP099192A ECSP099192A EC SP099192 A ECSP099192 A EC SP099192A EC SP099192 A ECSP099192 A EC SP099192A EC SP099192 A ECSP099192 A EC SP099192A
- Authority
- EC
- Ecuador
- Prior art keywords
- hlight
- antibodies
- fully human
- polypeptide
- immunospecifically
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Se proporcionan aquí anticuerpos, como por ejemplo anticuerpos totalmente humanos, que se unen inmunoespecíficamente a un polipéptido hLIGHT. Se proporcionan también ácidos nucleicos aislados que codifican anticuerpos, como por ejemplo anticuerpos totalmente humanos que se unen inmunoespecíficamente a un polipéptido hLIGHT. Se proporcionan además vectores y células hospederas que comprenden anticuerpos que codifican ácidos nucleicos, como por ejemplo anticuerpos totalmente humanos, que se unen inmunoespecíficamente a un polipéptido hLIGHT. Se proporcionan también métodos para preparar anticuerpos, como por ejemplo anticuerpos totalmente humanos, que se unen inmunoespecíficamente a un polipéptido hLIGHT. Se proporciona también aquí un método para tratar una enfermedad mediada por hLIGHT en un sujeto, que comprende la administración al sujeto de un anticuerpo, como por ejemplo un anticuerpo totalmente humano, que se une inmunoespecíficamente a un polipéptido hLIGHT. En modalidades preferidas, los anticuerpos anti-hLIGHT proporcionados aquí mejoran, neutralizan o inhiben de otra forma la actividad biológica hLIGHT in vivo (por ejemplo, la producción o secreción mediada por hLIGHT de CCL20, IL-8 o RANTES a partir de una célula que expresa un receptor hLIGHT). Se proporciona también aquí un método para detectar hLIGHT en una muestra así como un método para mejorar, neutralizar o inhibir de otra forma la actividad hLIGHT, por ejemplo, en un sujeto humano que padece de una enfermedad en donde la actividad hLIGHT es perjudicial.Antibodies, such as fully human antibodies, which bind immunospecifically to an hLIGHT polypeptide are provided herein. Isolated nucleic acids encoding antibodies are also provided, such as fully human antibodies that immunospecifically bind to an hLIGHT polypeptide. In addition, vectors and host cells comprising antibodies encoding nucleic acids, such as fully human antibodies, that bind immunospecifically to an hLIGHT polypeptide are provided. Methods for preparing antibodies, such as fully human antibodies, that bind immunospecifically to an hLIGHT polypeptide are also provided. A method is also provided here for treating a hLIGHT mediated disease in a subject, which comprises administering to the subject an antibody, such as a fully human antibody, that binds immunospecifically to an hLIGHT polypeptide. In preferred embodiments, the anti-hLIGHT antibodies provided herein enhance, neutralize or otherwise inhibit hLIGHT biological activity in vivo (eg, hLIGHT-mediated production or secretion of CCL20, IL-8 or RANTES from a cell that expresses an hLIGHT receiver). A method is also provided here to detect hLIGHT in a sample as well as a method to improve, neutralize or otherwise inhibit hLIGHT activity, for example, in a human subject suffering from a disease where hLIGHT activity is detrimental.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84077406P | 2006-08-28 | 2006-08-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP099192A true ECSP099192A (en) | 2009-06-30 |
Family
ID=41057664
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP099192 ECSP099192A (en) | 2006-08-28 | 2009-03-19 | SPECIFIC HUMAN MONOCLONAL ANTIBODIES FOR HUMAN LIGHT ANTAGONISTS |
Country Status (6)
| Country | Link |
|---|---|
| CN (1) | CN101663321B (en) |
| EC (1) | ECSP099192A (en) |
| HN (1) | HN2009000414A (en) |
| SI (1) | SI2292663T1 (en) |
| UA (1) | UA99714C2 (en) |
| ZA (1) | ZA200901165B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201701194D0 (en) * | 2017-01-24 | 2017-03-08 | Capella Bioscience Ltd | Antigen binding molecules that bind light |
| WO2021202649A2 (en) * | 2020-04-01 | 2021-10-07 | Aevi Genomic Medicine, Llc | Methods and treatment involving excess free light |
| WO2025195443A1 (en) * | 2024-03-21 | 2025-09-25 | 北京三诺佳邑生物技术有限责任公司 | Multi-specific antibody that specifically binds to light and c5a, and composition and use thereof |
| TW202602939A (en) * | 2024-04-06 | 2026-01-16 | 大陸商華深智藥生物科技（蘇州）有限公司 | A multispecific antibody T cell connector |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL136114A0 (en) * | 1997-11-14 | 2001-05-20 | Euro Celtique Sa | Immunoglobulin molecules having a synthetic variable region and modified specificity |
-
2007
- 2007-08-24 SI SI200731379T patent/SI2292663T1/en unknown
- 2007-08-24 ZA ZA200901165A patent/ZA200901165B/en unknown
- 2007-08-24 CN CN200780040270.3A patent/CN101663321B/en active Active
- 2007-08-24 UA UAA200902921A patent/UA99714C2/en unknown
-
2009
- 2009-02-27 HN HN2009000414A patent/HN2009000414A/en unknown
- 2009-03-19 EC ECSP099192 patent/ECSP099192A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI2292663T1 (en) | 2014-02-28 |
| UA99714C2 (en) | 2012-09-25 |
| HN2009000414A (en) | 2012-02-17 |
| ZA200901165B (en) | 2010-06-30 |
| CN101663321B (en) | 2014-10-08 |
| CN101663321A (en) | 2010-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NI200900027A (en) | HUMAN MONOCLONAL ANTIBODIES SPECIFIC TO LIGHT HUMAN ANTAGONISTS. | |
| EA202192103A1 (en) | ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS SPECIFIC TO ORPHAN RECEPTOR TYPE OF RECEPTOR TYROSINE KINASE 1 (ROR1) | |
| BR112012018914A2 (en) | "humanized antibody, antigen binding protein, nucleic acid molecule, expression vector, recombinant host cell, antibody or antigen binding protein, methods for producing an antigen binding protein and for treating a subject affected by an autoimmune or inflammatory disease, and, pharmaceutical composition. " | |
| EA201001139A1 (en) | IMPROVED ANTIBODY ANTI-TrkB | |
| EA200701292A1 (en) | COMPOSITIONS CONTAINING ANTIBODIES AGAINST THE IGF-1 RECEPTOR AND WAYS TO OBTAIN ANTIBODIES | |
| RU2017107773A (en) | ANTIBODIES SPECIFIC TO MMP9 | |
| EA200870021A1 (en) | HUMAN MONOCLONAL ANTIBODIES TO FUKOZIL-GM1 AND METHODS OF APPLICATION OF ANTI-FUKOSIL-GM1 ANTIBODIES | |
| Karlsen et al. | The proteomic profile of the human myotendinous junction | |
| BRPI0607315A2 (en) | isolated polynucleotide, expression vector, composition, method of producing an antigen binding molecule, antigen binding molecule and the use thereof, method for detecting in vivo or in vitro the presence of egfr in a sample, engineered host cell , pharmaceutical composition and its use | |
| MX2012004084A (en) | Siglec 15 antibodies in treating bone loss-related disease. | |
| EA200901436A1 (en) | Antigen-binding proteins that bind PAR-2 | |
| ECSP12011698A (en) | CEA ANTIBODIES | |
| EA201190041A1 (en) | HUMAN AUTOANTIBODIES AGAINST ALPHA-SINUCLEIN | |
| EA201490825A1 (en) | TDP-43-SPECIFICALLY BINDING MOLECULES | |
| EA200970263A1 (en) | FULLY HUMAN HIGH-PRODUCTIVE SYSTEM FOR OBTAINING IMPROVED ANTIBODIES AND PROTEINS | |
| PE20121129A1 (en) | HUMAN ANTIBODIES OF HIGH AFFINITY FOR HUMAN ANGIOPOYETIN-2 | |
| CO6680693A2 (en) | Recombinant human antibodies, both humanized and chimeric, which specifically bind human ox40 | |
| FR2933773B1 (en) | METHOD FOR DETERMINING THE ISOMERASE DISULFIDE PROTEIN FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER | |
| UA118646C2 (en) | Human oncostatin m antibodies and methods of use | |
| EA202091569A1 (en) | MONOCLONAL ANTIBODIES AND METHODS OF THEIR APPLICATION | |
| ECSP099192A (en) | SPECIFIC HUMAN MONOCLONAL ANTIBODIES FOR HUMAN LIGHT ANTAGONISTS | |
| Xu et al. | A subset of type-II collagen-binding antibodies prevents experimental arthritis by inhibiting FCGR3 signaling in neutrophils | |
| AR071885A1 (en) | PROTEINS OF UNION TO THE INTERLEUQUINE RECEIVER 21 | |
| BRPI0921261A2 (en) | antibodies that immunospecifically bind to modified human igf-1 peptides, hybridoma, isolated polypeptide, nucleic acid encoding an antibody, vector comprising a nucleic acid, host cell comprising a vector, improved enzyme linked immunosorbent assay (elisa), method of maintaining optimal dose of modified igf-1 / e, improved affinity chromatographic method and use of modified igf-1 / e. | |
| Liu et al. | Identification, Characterization, and Structure of Tm16 from Trichuris muris |